Joseph Douglas Lyon - Net Worth and Insider Trading

Joseph Douglas Lyon Net Worth

The estimated net worth of Joseph Douglas Lyon is at least $158,918 dollars as of 2024-03-01. Joseph Douglas Lyon is the Chief Accounting Officer of Corcept Therapeutics Inc and owns about 6,774 shares of Corcept Therapeutics Inc (CORT) stock worth over $158,918. Details can be seen in Joseph Douglas Lyon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph Douglas Lyon has not made any transactions after 2024-02-16 and currently still holds the listed stock(s).

Transaction Summary of Joseph Douglas Lyon

To

Joseph Douglas Lyon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Douglas Lyon owns 1 companies in total, including Corcept Therapeutics Inc () .

Click here to see the complete history of Joseph Douglas Lyon’s form 4 insider trades.

Insider Ownership Summary of Joseph Douglas Lyon

Ticker Comapny Transaction Date Type of Owner
Corcept Therapeutics Inc 2024-02-16 Chief Accounting Officer

Joseph Douglas Lyon Latest Holdings Summary

Joseph Douglas Lyon currently owns a total of 1 stock. Joseph Douglas Lyon owns 6,774 shares of Corcept Therapeutics Inc (CORT) as of February 16, 2024, with a value of $158,918.

Latest Holdings of Joseph Douglas Lyon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CORT Corcept Therapeutics Inc 2024-02-16 6,774 23.46 158,918

Holding Weightings of Joseph Douglas Lyon


Joseph Douglas Lyon Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph Douglas Lyon has made a total of 12 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Corcept Therapeutics Inc is the sale of 1,000 shares on February 16, 2024, which brought Joseph Douglas Lyon around $26,000.

Insider Trading History of Joseph Douglas Lyon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph Douglas Lyon Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joseph Douglas Lyon Ownership Network

Ownership Network List of Joseph Douglas Lyon

No Data

Ownership Network Relation of Joseph Douglas Lyon


Joseph Douglas Lyon Owned Company Details

What does Corcept Therapeutics Inc do?

Who are the key executives at Corcept Therapeutics Inc?

Joseph Douglas Lyon is the Chief Accounting Officer of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include See Remarks Sean Maduck , Chief Development Officer William Guyer , and CHIEF FINANCIAL OFFICER Gary Charles Robb .

Corcept Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Joseph Douglas Lyon made 9 insider transaction in Corcept Therapeutics Inc () with a net sale of 36,000. Other recent insider transactions involving Corcept Therapeutics Inc () include a net sale of 182,453 shares made by Sean Maduck , a net sale of 17,600 shares made by Swisher Daniel N Jr , and a net sale of 134,994 shares made by Gary Charles Robb .

In summary, during the past 3 months, insiders sold 59,821 shares of Corcept Therapeutics Inc () in total and bought 0 shares, with a net sale of 59,821 shares. During the past 18 months, 426,502 shares of Corcept Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 426,502 shares.

Corcept Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Corcept Therapeutics Inc Insider Transactions

No Available Data

Joseph Douglas Lyon Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Douglas Lyon. You might contact Joseph Douglas Lyon via mailing address: C/o Corcept Therapeutics Incorporated, 149 Commonwealth Drive, Menlo Park Ca 94025.

Discussions on Joseph Douglas Lyon

No discussions yet.